{"task_id": "2bdfe443e3366b4b", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 227/464)", "text": "romatase\nin adipose tissue)\n216\nEndometrial Cancer\n\n--- Page 238 ---\nPATHOPHYSIOLOGY (CONT\u2019D)\n\u0002\nFAMILY HISTORY\nHNPCC\n\u0002\nDISEASES\novarian granulosa cell and theca cell\ntumors (produce estrogen), polycystic ovary dis\nease (chronic anovulation), diabetes (2\u0003), tamox\nifen (3 7\u0003), unopposed estrogen administration\n(i.e. without progesterone, 6\u0003)\nCLINICAL FEATURES\nSYMPTOMS\n\u0002\nLOCOREGIONAL\nabnormal vaginal bleed (97%, par\nticularly in postmenopausal women), pelvic pain,\npelvic mass, constipation, bowel obstruction,\nabdominal pain, abdominal bloating/distension,\nrenal failure, urinary frequency\n\u0002\nMETASTATIC\ndyspnea, cough, abdominal pain, sei\nzures, bony pain\n\u0002\nCONSTITUTIONAL\nweight loss, anorexia, fatigue\nPROGNOSTIC ISSUES\nADVERSE\nPROGNOSTIC\nFACTORS\nadvanced\nstage, high grade, papillary serous carcinoma, small\ncell carcinoma, vascular invasion, ER negative, PR\nnegative, DNA ploidy\nSTAGING\nREVISED FIGO STAGING 2009\nSTAGE I\nconfined to the corpus uteri\n\u0002 IA=no or less than half myometrial invasion\n\u0002 IB=invasion equal to or more than half of the\nmyometrium\nSTAGE II\ninvolves cervical stroma\n\u0002 II=invades cervical stroma, but does not extend\nbeyond the uterus\nSTAGE III\nlocal and regional spread of the tumor\n\u0002 IIIA=invades the serosa of the corpus uteri and/\nor adnexae\n\u0002 IIIB=vaginal and/or parametrial involvement\n\u0002 IIIC=metastases to pelvic and/or para aortic\nLN\n\u0002 IIIC1=pelvic nodes\n\u0002 IIIC2=para aortic lymph nodes with or with\nout positive pelvic lymph\nSTAGE IV\nextends outside the true pelvis\n\u0002 IVA=invasion of bladder and/or bowel mucosa\n\u0002 IVB=distant metastases, including intra abdom\ninal metastases and/or inguinal LN\nGRADE\n\u0002 G1=well differentiated (\u00045% of solid growth\npattern)\n\u0002 G2=moderately differentiated (6 50%)\n\u0002 G3=undifferentiated (>50%)\nSTAGING (CONT\u2019D)\nOVERALL SURVIVAL BY STAGE\nSurgical stage\nFreq\n5 year survival\nIA B\n75%\n80 90%\nII\n11%\n70%\nIIIA C\n11%\n50%\nIVA B\n3%\n20 30%\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, AST, ALT, ALP, bilir\nubin, CA 125\n\u0002\nIMAGING\nCXR\n\u0002\nBIOPSY\nendometrial curettage with endocervi\ncal sampling, dilation and curettage, colono\nscopy (if symptomatic or relevant family history\nsuggestive of HNPCC)\nSPECIAL\n\u0002\nADDITIONAL IMAGING\ntransvaginal U/S (not rou\ntinely required), CT abd/pelvis (not routinely\nrequired), MR pelvis with gadolinium (most sen\nsitive but not routinely required)\nMANAGEMENT\nSTAGE I\nTAH/BSO \u0006 lymphadenectomy (highly\ncontroversial). If high risk features such as stage 1C\n(>50% muscle invasion), grade 3, vascular invasion,\npapillary serous or clear cell histology, consider adju\nvant radiotherapy to pelvis to reduce local recur\nrence rate\nSTAGE II\nsurgery (TAH/BSO \u0006 lymphadenectomy),\nfollowed by adjuvant radiotherapy to pelvis to\nreduce local recurrence rate\nSTAGE III\nsurgery (TAH/BSO \u0006 lymphadenect\nomy), followed by adjuvant chemotherapy (gener\nally a platinum taxane combination with or without\ndoxorubicin)\nSTAGE IV OR LOCALLY RECURRENT DISEASE\n\u0002\nEXENTERATION\npotentially curable if isolated cen\ntral recurrence\n\u0002\nPELVIC RADIATION\nif central local recurrence and\nnot previously irradiated\n\u0002\nHORMONAL AGENTS\nfor grade 1 2 disease, con\nsider hormonal therapy with megestrol acetate\n160 mg PO daily, medroxyprogesterone 1 g IM\nweekly \u00036 weeks and then monthly, or tamoxifen\n20 mg PO daily. Response rate 20 30%, response\nduration 4 months. Predictors for hormonal ther\napy include well differentiated tumors (G1 2),\nER/PR+ tumors, and long progression free survival\nbefore recurrence\nEndometrial Cancer\n217", "text_length": 3490, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 227/464)", "type": "chunk", "chunk_index": 226, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.559334", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.560060", "status": "complete", "chunks_added": 2}